Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Convertible Preferred Stock and Shareholders??? Equity (Deficit)

v3.22.1
Condensed Consolidated Statements of Convertible Preferred Stock and Shareholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Initially reported
Retroactive application of exchange ratio
Common stock
Common stock
Initially reported
Common stock
Retroactive application of exchange ratio
Additional paid in capital
Additional paid in capital
Initially reported
Additional paid in capital
Retroactive application of exchange ratio
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Initially reported
Accumulated other comprehensive loss
Retroactive application of exchange ratio
Accumulated deficit
Accumulated deficit
Initially reported
Accumulated deficit
Retroactive application of exchange ratio
Temporary equity, beginning balance (in shares) at Dec. 31, 2020 117,886,982 58,554,536 59,332,446                        
Temporary equity, beginning balance at Dec. 31, 2020 $ 45,932 $ 45,932 $ 0                        
Temporary equity, ending balance (in shares) at Mar. 31, 2021 117,886,982                            
Temporary equity, ending balance at Mar. 31, 2021 $ 45,932                            
Beginning balance (in shares) at Dec. 31, 2020       8,160,828 4,053,489 4,107,339                  
Beginning balance at Dec. 31, 2020 (27,862) $ (27,862) $ 1 $ 4 $ (3) $ 1,309 $ 1,306 $ 3 $ 0 $ 0 $ 0 $ (29,172) $ (29,172) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net loss (4,056)                       (4,056)    
Other comprehensive loss (12)                 (12)          
Share-based compensation 211           211                
Shares issued for stock options exercised (in shares)       2,173,524                      
Shares issued for stock options exercised 214           214                
Shares issued for stock warrants exercised (in shares)       199,315                      
Shares issued for stock warrants exercised 30           30                
Ending balance at Mar. 31, 2021 $ (31,475)     $ 1     1,764     (12)     (33,228)    
Ending balance (in shares) at Mar. 31, 2021       10,533,667                      
Temporary equity, beginning balance (in shares) at Dec. 31, 2021 0                            
Temporary equity, beginning balance at Dec. 31, 2021 $ 0                            
Temporary equity, ending balance (in shares) at Mar. 31, 2022 0                            
Temporary equity, ending balance at Mar. 31, 2022 $ 0                            
Beginning balance (in shares) at Dec. 31, 2021       183,367,037                      
Beginning balance at Dec. 31, 2021 214,058     $ 18     380,624     (4)     (166,580)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net loss (58,968)                       (58,968)    
Other comprehensive loss (380)                 (380)          
Share-based compensation 12,982           12,982                
Shares issued for stock options exercised (in shares)       2,754,244                      
Shares issued for stock options exercised 272     $ 1     271                
Project Warrants and Collaboration Warrants Compensation (see Note 3) 9,339           9,339                
Ending balance at Mar. 31, 2022 $ 177,303     $ 19     $ 403,216     $ (384)     $ (225,548)    
Ending balance (in shares) at Mar. 31, 2022       186,121,281